The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter.

In an article published in The New England Journal of Medicine titled “An Evidence-Based Approach to Covid-19 Vaccination” by Vinay Prasad and Martin Makary, the pair of FDA leaders said: “While all other high-income nations confine vaccine recommendations to older adults (typically those older than 65 years of age),

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat